secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2026-06-10T20:05:16+00:00
Accession:  0001193125-26-265804
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences shareholders approve doubling of authorized common stock to 480M
--------------------------------------------------------------------------------

- Approved charter amendment increasing authorized common shares from 240M to 480M; filed June 10, 2026.
- Elected Class II directors Clare Kahn, Adam Stone, and Lynne Sullivan with overwhelming votes (73M+ each).
- Ratified PricewaterhouseCoopers as independent auditor for FY2026 with 86.4M votes for, 70K against.
- Advisory say-on-pay passed with 72.6M votes for and 6.2M against; broker non-votes 7.7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526265804/0001193125-26-265804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526265804/sldb-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-265804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer